DE69840457D1 - Verfahren und Zwischenprodukte zur Herstellung 2-substituierter Piperidinstereoisomere - Google Patents

Verfahren und Zwischenprodukte zur Herstellung 2-substituierter Piperidinstereoisomere

Info

Publication number
DE69840457D1
DE69840457D1 DE69840457T DE69840457T DE69840457D1 DE 69840457 D1 DE69840457 D1 DE 69840457D1 DE 69840457 T DE69840457 T DE 69840457T DE 69840457 T DE69840457 T DE 69840457T DE 69840457 D1 DE69840457 D1 DE 69840457D1
Authority
DE
Germany
Prior art keywords
erythro
stereoisomers
carbon atoms
threo
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69840457T
Other languages
English (en)
Inventor
Sowmianarayanan Ramaswamy
Vikram Khetani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celgene Corp
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Application granted granted Critical
Publication of DE69840457D1 publication Critical patent/DE69840457D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE69840457T 1997-01-31 1998-05-26 Verfahren und Zwischenprodukte zur Herstellung 2-substituierter Piperidinstereoisomere Expired - Lifetime DE69840457D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/792,661 US5965734A (en) 1997-01-31 1997-01-31 Processes and intermediates for preparing 2-substituted piperidine stereoisomers
EP05077084A EP1612207B1 (de) 1997-01-31 1998-05-26 Verfahren und Zwischenprodukte zur Herstellung 2-substituierter Piperidinstereoisomere
PCT/US1998/010599 WO1999061425A1 (en) 1997-01-31 1998-05-26 Processes and intermediates for preparing 2-substituted piperidine stereoisomers

Publications (1)

Publication Number Publication Date
DE69840457D1 true DE69840457D1 (de) 2009-02-26

Family

ID=26794135

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69840457T Expired - Lifetime DE69840457D1 (de) 1997-01-31 1998-05-26 Verfahren und Zwischenprodukte zur Herstellung 2-substituierter Piperidinstereoisomere
DE69831611T Expired - Lifetime DE69831611T2 (de) 1997-01-31 1998-05-26 Verfahren und zwischenprodukte zur herstellung 2-substituierter piperidin-stereoisomere

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69831611T Expired - Lifetime DE69831611T2 (de) 1997-01-31 1998-05-26 Verfahren und zwischenprodukte zur herstellung 2-substituierter piperidin-stereoisomere

Country Status (13)

Country Link
US (1) US5965734A (de)
EP (2) EP1082307B1 (de)
JP (1) JP4491135B2 (de)
AT (2) ATE304531T1 (de)
AU (1) AU765194B2 (de)
CA (1) CA2333089C (de)
CY (1) CY1108818T1 (de)
DE (2) DE69840457D1 (de)
DK (2) DK1082307T3 (de)
ES (2) ES2249830T3 (de)
HK (1) HK1090915A1 (de)
PT (1) PT1612207E (de)
WO (1) WO1999061425A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US6962997B1 (en) * 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
US6359139B1 (en) * 2000-11-07 2002-03-19 Celgene Corporation Methods for production of piperidyl acetamide stereoisomers
US20020187192A1 (en) * 2001-04-30 2002-12-12 Yatindra Joshi Pharmaceutical composition which reduces or eliminates drug abuse potential
AU2002332659A1 (en) * 2001-08-21 2003-03-03 Sepracor, Inc. 2-substituted piperidines that are ligands for monoamine receptors and transporters
US6638533B2 (en) 2002-01-03 2003-10-28 George Krsek Pulse dosage formulations of methylphenidate and method to prepare same
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
CA2591247A1 (en) * 2004-12-09 2006-06-15 Celgene Corporation Treatment of patients suffering from a disease having a family history or diagnosis of tics or tourette's syndrome with d-threo methylphenidate
ITMI20042415A1 (it) * 2004-12-17 2005-03-17 Clariant Lsm Italia Spa Sintesi di alfa-aril-alfa-piperid-2-il-acetammidi e loro idrolisi acida
US9233924B2 (en) 2014-03-11 2016-01-12 Ampac Fine Chemicals Llc Methods for preparing D-threo methylphenidate using diazomethane, and compositions thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2507631A (en) * 1944-01-19 1950-05-16 Ciba Pharm Prod Inc Pyridine and piperidine compounds and process of making same
US2957880A (en) * 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
JPS5630978A (en) * 1979-08-24 1981-03-28 Kyowa Hakko Kogyo Co Ltd Novel mitomycin and its preparation
US4978744A (en) * 1989-01-27 1990-12-18 Arizona Board Of Regents Synthesis of dolastatin 10
US5075315A (en) * 1990-05-17 1991-12-24 Mcneilab, Inc. Antipsychotic hexahydro-2H-indeno[1,2-c]pyridine derivatives
US5597915A (en) * 1992-03-16 1997-01-28 Merck Sharp & Dohme Ltd. Benzodiazepine derivatives, compositions containing them and their use in therapy
ATE206402T1 (de) * 1993-11-22 2001-10-15 Merck & Co Inc 3-acylaminobenzazepine
EP0771789B1 (de) * 1995-10-30 2000-02-16 F. Hoffmann-La Roche Ag 1-Alpha, 26-dihydroxy-D-homo-vitamin D3
DE19615119A1 (de) * 1996-04-17 1997-10-23 Bayer Ag Neue Arylessigsäureamide

Also Published As

Publication number Publication date
US5965734A (en) 1999-10-12
ATE304531T1 (de) 2005-09-15
PT1612207E (pt) 2009-02-04
CA2333089A1 (en) 1999-12-02
AU7595098A (en) 1999-12-13
CA2333089C (en) 2008-10-14
EP1612207B1 (de) 2009-01-07
ES2320012T3 (es) 2009-05-18
DK1612207T3 (da) 2009-05-04
HK1090915A1 (en) 2007-01-05
WO1999061425A1 (en) 1999-12-02
ES2249830T3 (es) 2006-04-01
CY1108818T1 (el) 2014-04-09
DK1082307T3 (da) 2005-12-19
EP1082307B1 (de) 2005-09-14
AU765194B2 (en) 2003-09-11
EP1612207A1 (de) 2006-01-04
JP4491135B2 (ja) 2010-06-30
DE69831611D1 (de) 2005-10-20
ATE420073T1 (de) 2009-01-15
EP1082307A4 (de) 2004-04-14
JP2002516313A (ja) 2002-06-04
EP1082307A1 (de) 2001-03-14
DE69831611T2 (de) 2006-06-14

Similar Documents

Publication Publication Date Title
CY1108818T1 (el) Μεθοδοι και ενδιαμεσοι δια παρασκευην στερεοϊσομερων 2-υποκατεστημενης πιπεριδινης
ATE217872T1 (de) Säureadditionssalze einer optisch aktiven piperidinverbindung und verfahren zu seiner herstellung
ATE292116T1 (de) Verfahren zur herstellung von donepezilderivaten
DE69706366D1 (de) Verfahren zur Herstellung von Paroxetine
EP1506961A3 (de) Verfahren und Zwischenprodukte zur Trennung von Piperidylacetamid-Stereoisomeren
ATE343385T1 (de) Verfahren zur herstellung von donepezil
ATE215521T1 (de) Herstellung von optisch aktiven 2-halogen-1- (substituiertem phenyl)-ethanol und substituiertem styroloxid
ATE334972T1 (de) Verfahren für die herstellung von 4(5)-amino-5(4)-carboxamidoimidazolen und deren zwischenprodukte
ATE189453T1 (de) Verfahren zur herstellung von 2-cyanobiphenyl- verbindungen
ATE520679T1 (de) Verfahren zur herstellung von (dioxolenon-4- yl)methylester-derivate
KR860004004A (ko) 4-아실옥시-3-옥소- 부티르산 에스테르의 제조방법
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
ATE319722T1 (de) Verfahren zur herstellung von vitamin-d analogen
ATE131483T1 (de) Verfahren zur herstellung von penemen
ATE129231T1 (de) Verfahren zur herstellung von optisch aktiven norbornylaminderivaten.
ATE260264T1 (de) Verfahren zur herstellung von oxazol-derivaten
DE60010918D1 (de) Verfahren zur herstellung von 7-azabicyclo (4.1.0)-hept-3-ene-3-carbonsäureestern
DE60323308D1 (de) Verfahren zur Herstellung von n-alkoxycarbonyl-piperidin Derivaten sowie Zwischenverbindungen dafür
ATE234806T1 (de) Verfahren zur herstellung von 2-alkyliden-4- bromacetessigsäureestern
KR920007984A (ko) 지방족 아미드 및 그의 염의 제조방법
DE3675761D1 (de) Verfahren zur herstellung von alpha-hydroxycarbonsaeureamiden.
ATE359990T1 (de) Verfahren zur herstellung von 3,5- bisalkylphenolen
KR970010774A (ko) 7-아미노-3-클로로-3-세펨-4-카르복실산의 제조방법
DE68906654D1 (de) Verfahren zur herstellung von konjugierten dienen.
ATE165814T1 (de) Verfahren zur herstellung von 5-oxohexannitrilen und die verbindung 2,4-dimethyl-5-oxo- hexannitrile

Legal Events

Date Code Title Description
8364 No opposition during term of opposition